Suzhou Alphamab Co., Ltd.

This is the first study in people to test a new injectable drug called KN069. It aims to check if the drug is safe and how it affects the body in 36 Chinese men who are overweight or have obesity. Researchers will also measure early signs of its effect on body weight and waist si…

This early-stage study is testing a new drug called KN060 in patients with end-stage kidney disease who are on regular dialysis. The main goal is to see if the drug is safe and if it can help prevent dangerous blood clots from forming in the dialysis machine tubing and in the pat…

This early-stage study is testing a new drug called KN060 to see if it can safely lower high blood pressure. About 60 adults with high blood pressure will receive either the drug or a placebo (inactive solution) via an IV drip every two weeks for 12 weeks. Researchers will compar…